Adverse Drug Events Reporting Features

• Continuing Melanoma Research: Why, How, What?   Dr Teresa Amaral discusses why it is important to continue speaking about melanoma.
  Medscape Oncology, January 06, 2025
• HBP: What Happened in the 1930s Should Stay There   Christopher Labos, MD CM, MSc, makes sense of nearly 100 years of blood pressure recommendations.
  Medscape Family Medicine, January 03, 2025
• Conference MDAngle: SABCS 2024 Hormone Receptor (HR)–Positive, HER2-Negative Breast Cancer Drs Armaghani and Henry share SABCS 2024 highlights, including anticipated presentations, quick takeaways, and insights into how new research will affect their patients.
  Medscape, January 02, 2025
• Conference MDAngle: ASH 2024 Paroxysmal Nocturnal Hemoglobinuria Dr Ilene Weitz shares ASH 2024 highlights, including anticipated presentations, quick takeaways, and insights into how new research will affect her patients.
  Medscape, January 02, 2025
• Cancer Survivors: A Rising Population With Big Implications   Dr Maurie Markman discusses the implications of a growing population of cancer survivors in the United States.
  Medscape Oncology, December 30, 2024
• DLBCL Highlights From ASH 2024   Dr John Leonard shares key updates on DLBCL at ASH 2024, including long-term POLARIX trial data, ctDNA insights, and real-world results for polatuzumab, liso-cel, and bispecifics after CAR-T failure.
  Medscape, December 30, 2024
• Chronic Myeloid Leukemia Highlights From ASH 2024   Highlights in chronic myeloid leukemia from ASH 2024 include data on efficacy of asciminib over TKIs, benefit from the third-generation TKI olverembatinib, and importance of molecular monitoring.
  Medscape, December 30, 2024
• Conference MDAngle: ASH 2024 Chronic Myeloid Leukemia Dr Lindsay Rein shares ASH 2024 highlights regarding CML, including anticipated presentations, quick takeaways, and insights into how new research will affect her patients.
  Medscape, December 27, 2024
• ASH 2024: Impact of New CML Treatments   Dr Lindsay Rein highlights how new CML data bring important considerations for clinical practice, patient tolerance, and the impact of treatment costs on quality of life.
  Medscape, December 27, 2024
• Progression on Systemic Therapy: Additional Considerations   Dr Mark Kris continues a discussion about considerations related to the many faces of progression on systemic therapy.
  Medscape Oncology, December 26, 2024
• ASH 2024: The Clinical Impact of New CLL Data   Dr Suchitra Sundaram reflects on how ASH updates will address her patients' questions about the value of MRD testing in CLL treatment.
  Medscape, December 26, 2024
• Disrupting the Status Quo: We Need More Pragmatic Trials   Dr Maurie Markman discusses the need for pragmatic trials to help patients with advanced cancer.
  Medscape Oncology, December 23, 2024
• The Year in Gastroenterology: 10 Must-Read Studies In a year of pivotal gastroenterology research, these 10 articles were in a class of their own, according to Dr David Johnson.
  Medscape Gastroenterology, December 23, 2024
• New Directions in Anemia and Related Disorders From ASH 2024   Strategies to reduce disease burden in alpha- or beta-thalassemia, sickle cell disease, and polycythemia vera, and insights into anemia in IBD, are among anemia highlights from ASH 2024.
  Medscape, December 23, 2024
• Dec 20 2024 This Week in Cardiology   Listener feedback, multiple studies in AF ablation, a DANISH trial substudy of ICDs in NICM, and more data on eye complications of GLP-1 agonists are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, December 20, 2024
• SABCS 2024: Insights on New Data in HR+/HER2- Breast Cancer   Dr Armaghani highlights breakthroughs from the 2024 San Antonio Breast Cancer Symposium, including new therapies for high-risk breast cancer.
  Medscape, December 20, 2024
• How to Assess Cancer Progression Beyond Imaging Results   Dr Mark Kris discusses the many faces of progression on systemic therapy.
  Medscape Oncology, December 17, 2024
• Gout: Diagnosis and Management in Primary Care   Physicians must consider questions related to medications, lifestyle advice, and long-term follow-up for their patients with gout.
  Medscape Family Medicine, December 12, 2024
• Have Your Cake and Eat It, Too: 'The Great British Bake Off'   Prof David Kerr discusses results from a study investigating ingredients in Christmas desserts from 'The Great British Bake Off,' noting that you can have your cake and eat it, too.
  Medscape Oncology, December 12, 2024
• Psoriatic Arthritis Highlights From ACR Convergence 2024   Highlights in psoriatic arthritis from ACR 2024 include results of methotrexate added to DMARD therapy, responses to bimekizumab, and improvements gained by upadacitinib after prior TNF inhibitor use.
  Medscape, December 11, 2024